Search results for: 'generic drug market'

There is growing pressure on the global power sector to decarbonize, which in turn puts pressure on new investment in coal-fired power generation. Energy security is a significant mega trend, whose importance is heightened by the Russo-Ukrainian War and the resulting disruption in the global power market. Many of the traditional high coal dependenc...

Pharmaceutical companies spend billions of dollars in drug development because of expensive and time-consuming clinical trials, with a meager success rate. Frequent clinical visits, manual data processing, and a lack of consistent data on the effectiveness of the investigation of medical products contribute to their low success rate. Digital bio...

Much like conventional firewalls, next-generation firewalls (NGFWs) filter network traffic based on predetermined security rules but have evolved to include granular application-layer visibility and control capabilities, enabling organizations to examine data traffic more deeply. With the traditional security perimeter of organizations slowly disap...

Generative AI (GenAI) has garnered huge interest and holds great promise for optimizing business operations by automating routine tasks, streamlining workflows, and providing intelligent insights that improve efficiency, quality, and performance. Ongoing innovation in artificial intelligence (AI) has introduced GenAI with far-reaching implicatio...

02 May 2023  |  Global  |  Technology Research

Technology Advances in Senolytics

Innovative Drug Development Culture Working to Prolong Health Spans and Eliminate Aging Cells

Infographics

×

Senolytics is a relatively new field of development that falls under the broad category of senotherapeutics, along with senomorphics and senostatics. Although nascent, the field could address the root causes of most chronic conditions brought on by aging as it clears senescent cells that have ceased to multiply (and ideally are eliminated from the ...

Organ-on-a-chip technology involves the incorporation of microphysiological systems harboring dynamic living 3D organoids, tissue-culture, or cell cultures on a microfluidic platform. The physiologically relevant Organ-chip models offer a better and more precise insight to the possible in vivo effects of drugs in the human body. The flexibility of ...

Globally, diagnosis of metabolic diseases such as type 2 diabetes and obesity have increased. Since the COVID-19 pandemic, the global prevalence of obesity has worsened. Obesity is considered a main precursor of diabetes and contributes an estimated 80% to 85% toward the risk of type 2 diabetes. As a result, the financial burden associated with hea...

Generative artificial intelligence (GenAI) is emerging as a game changer in the chemicals and materials industry. This technology, which combines advanced machine learning with vast data resources, has the potential to transform the industry by driving innovation, efficiency, and ecologically sound practices. Gen AI allows for faster research and d...

The global pharmaceutical industry strives to build an inclusive partner ecosystem that integrates technology, data, and regulatory standardization-enabled innovation into clinical trial delivery. This transformation aims to reduce the burden on investigators and sites while improving the efficiency and accuracy of adverse event (AE) tracking. Driv...